Fiscal Year 2022
Released June, 2021
Topics on this page: Goal 4. Objective 4 | Objective 4.4 Table of Related Performance Measures
Goal 4. Objective 4: Leverage translational research, dissemination and implementation science, and evaluation investments to support adoption of evidence-informed practices
Translational research, dissemination, and implementation science help increase understanding about how best to support knowledge, adoption, and faithful implementation of best practices in the community. Selecting and adopting evidence-based approaches to tackle health, public health, and human services challenges can be a complex undertaking. HHS programs balance requirements to implement high-quality programs with fidelity, while acknowledging the unique needs of specific individuals or target populations, recognizing differences in program and community settings and resources, and respecting linguistic or cultural differences. Understanding threats to successful implementation of a promising practice can help the Department prevent and mitigate those risks early.
In the previous administration, the Office of the Secretary led this objective. The following divisions are responsible for implementing programs under this strategic objective: ACF, ACL, AHRQ, CDC, FDA, HRSA, NIH, OASH, and SAMHSA. HHS has determined that performance toward this objective is progressing. The narrative below provides a brief summary of progress made and achievements or challenges, as well as plans to improve or maintain performance.
Objective 4.4 Table of Related Performance Measures
Increase the percentage of Community-Based Child Abuse Prevention (CBCAP) total funding that supports evidence-based and evidence-informed child abuse prevention programs and practices (Lead Agency - ACF; Measure ID - 7D)
| Measure | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 |
|---|---|---|---|---|---|---|---|---|
| Target | 64.1 % | 62.4 % | 57.3% | 56.4% | 64.5% | 65.8% | Prior Result +3PP | Prior Result +3PP |
| Result | 59.4 % | 53.4% | 53.4% | 61.5% | 62.8% | 10/30/21 | 10/30/22 | 10/30/23 |
| Status | Target Not Met | Target Not Met | Target Not Met | Target Exceeded | Target Not Met, but Improved | Pending | Pending | Pending |
Currently, the Children's Bureau and its National Center for CBCAP are working closely with the states to promote more rigorous evaluations of their funded programs. The Children's Bureau defines evidence-based and evidence-informed programs and practices along a continuum. The continuum includes four categories of programs or practices: Emerging and Evidence Informed; Promising; Supported; and Well-Supported.
The FY 2018 result represented an increase with grantees reporting 61.5 percent of funds directed at evidence-based practices, which then increased again in FY 2019 with an actual result of 62.8 percent. ACF will continue to promote evaluation and innovation to expand the availability and use of evidence-informed and evidence-based practice over time. In FY 2021 and FY 2022, ACF is committed to continuing to work with CBCAP grantees to invest in known evidence-based practices, as well as to focus on one-on-one and peer learning technical assistance on increased accuracy of data reporting for this measure.
By 2020, develop and test the effectiveness of two strategies for translating cancer knowledge, clinical interventions, or behavioral interventions to underserved communities in community-based clinical settings (Lead Agency - NIH; Measure ID - SRO-5.1)
| Fiscal Year | Target | Result | Status |
|---|---|---|---|
| FY 2014 | N/A | N/A | N/A |
| FY 2015 | N/A | N/A | N/A |
| FY 2016 | N/A | N/A | N/A |
| FY 2017 | Develop two strategies for translating validated basic knowledge, clinical interventions, or behavioral interventions to diverse communities and clinical practice through establishing the Partnerships to Advance Cancer Health Equity (PACHE) program between Minority Serving Institutions (MSI) and NCI-designated Cancer Centers (CC). | Several U54 PACHE Partnerships have developed and/or validated evidence-based interventions and tools to help reduce the burden of cancer disparities in underserved communities across the United States. They are working with various community-based organizations (including faith-based organizations and community-based clinical practices and organizations) to disseminate/translate the interventions and tools in the diverse communities. | Target Met |
| FY 2018 | Develop and support two partnerships to test validated basic cancer knowledge, clinical or behavioral interventions to diverse communities in clinical practice. | The U54 PACHE Partnerships, through 2 new efforts, developed and/or validated evidence-based interventions and tools to help reduce the burden of cancer disparities in underserved communities across the United States. These partnerships continued to work with various community-based organizations (including faith-based organizations and community-based clinical practices and organizations) to disseminate/translate the interventions and tools for use in diverse communities. | Target Met |
| FY 2019 | Finalize testing and validating the strategies to translate basic cancer knowledge, clinical or behavioral interventions to underserved communities and into clinical practice. | Two U54 PACHE partnerships finalized testing and validating evidence-based interventions and tools to help translate basic cancer knowledge and clinical or behavioral interventions to underserved communities across the United States. They continue to work with various community-based organizations to disseminate these interventions and tools. | Target Met |
| FY 2020 | Finalize testing and validating the strategies to translate basic cancer knowledge, clinical or behavioral interventions to underserved communities and into clinical practice. | Building on earlier efforts, two U54 PACHE partnerships validated strategies to help translate basic cancer knowledge and clinical or behavioral interventions to underserved communities across the United States and U.S. territories. These partnerships continue to work with various community-based organizations to disseminate these interventions and to assess their effectiveness in promoting health equity. | Target Met |
NIH's Partnerships to Advance Cancer Health Equity (PACHE) is a program that fosters partnerships among institutions serving underserved health disparity populations, underrepresented students, and National Cancer Institute-designated Cancer Centers. PACHE partnerships train scientists from diverse backgrounds in cancer research and to effectively deliver knowledge on cancer to underserved communities.
PACHE partnerships continued to flourish in FY 2020. For example, one partnership developed interventions led by trained community health advisors in collaboration with churches to promote cancer screening in African American and Latinos communities in the South Los Angeles area. This partnership resulted in raised awareness about cancer screening tests and led to a better understanding of regional differences in screening rates that could inform future interventions for African American communities in South Los Angeles. Another partnership continues to work with faith-based and community-based organizations to advance health equity in Guam, Hawai'i, and the US-associated Pacific Islands through cancer research, training, and outreach. The partnership has contributed to the passage of significant cancer prevention and control legislation in Hawaii, Guam, and Saipan, including Hawaii's recent administrative rules change (HAR 11-167) requiring HPV vaccination for seventh grade entry, effective July 1, 2020. As a result, Hawaii is now one of only two states nationwide with this school entry requirement.
This measure has been completed and discontinued. However, NIH remains committed to funding future projects to develop and assess new strategies to help bring cancer advances to underserved communities.
<< Return to Topics in this ReportTop of pageGoal 5. Objective 1 >>
